Phoenix Life Sciences International Announces Dr. Santus Wari as Company's National Head of Healthcare
28 Marzo 2019 - 7:00AM
InvestorsHub NewsWire
Phoenix Life
Sciences International Announces Dr. Santus Wari as Company's
National Head of Healthcare in the Republic of Vanuatu
DENVER, CO
March 28, 2019 -- InvestorsHub NewsWire
-- Phoenix
Life Sciences International Limited (OTC: PLSI) ("Phoenix Life" or the
"Company"), an adaptive healthcare solutions company, today
announced that Dr. Santus Wari has joined the company as Head
of National Healthcare for the Republic of Vanuatu.
Dr. Santus Wari is
the former Acting Director of the Vanuatu Department of Curative
& Hospital Services and former Vanuatu Ministry of Health
Director General of Health. He was also the Medical Superintendent
for the Vila Central Hospital and Northern Provincial Hospital in Vanuatu at varying
times. Dr. Wari served as the Senior Consulting Surgeon for the
Ministry of Health during his 25 years as a surgeon and, prior to
joining the government of Vanuatu, he gained formal medical
training under the supervision of the Australian Medical
Support to Vanuatu.
He holds Bachelor's degrees of Medicine
and Surgery from The University of the South Pacific and a Post
Graduate degree in General Surgery from The Fiji School of
Medicine. Serving the medical needs of
the Republic of Vanuatu, Dr. Santus Wari retired in 2018.
"Dr.
Santus
Wari holds a strong
reputation in Vanuatu's medical community, and we're honored that he has
agreed to spearhead operations for the National
Network of Community Clinics and Dispensing Pharmacies, to address
and provide solutions for the national diabetes epidemic. Further,
Dr.
Santus
Wari
joins
the research team
as a lead investigator for clinical trials for our
cannabinoid-based Type 2 diabetes management product,
Phoenix Metabolic, adding greater experience in
Pacific Island communities." said Phoenix Life
Sciences International
CEO Martin Tindall.
"As we continue to build out our expert team, I look forward to
seeing what our collaborative knowledge, experience, and
relationships can bring to our potentially life-changing
efforts."
"Having worked
directly with the local hospitals and healthcare clinics in
Vanuatu, I have seen first-hand how prominent the country's
diabetes epidemic has become and the need for citizens to have a
more accessible, safe and affordable alternative treatment to
address the disease," said Phoenix Life Head of National Healthcare Dr. Santus Wari.
"Alongside Phoenix Life, I look forward to not only building out
the company's efforts in Vanuatu, but also helping to change
healthcare around the world."
Phoenix Life, with
the assistance of Dr. Wari, plans to continue building out its
network of Community Clinics and Dispensing Pharmacies throughout
Vanuatu. These clinics will greatly expand the country's diabetes
treatment options by providing preventative blood sugar
testing,
dispensing pharmacies and other services to promote the health of
the local people.
To learn more about
Phoenix Life Sciences International, please visit
https://phoenixlife.co/ or
for the local Vanuatu website to register or for more local
information please visithttps://phoenixlife.vu.
###
About Phoenix
Life Sciences International Limited
Phoenix Life
Sciences International Limited is an adaptive healthcare solutions
company. Our business is to advance research and integrate programs
and manufacturing of products that target and treat diabetes, pain,
cancer, and address psychological, gastrointestinal, autoimmune,
neurological and sleep disorders. We strive to create partnerships
and integrate these programs for human health into communities
worldwide as part of our Global Health Initiative.
FORWARD-LOOKING
STATEMENTS
Information
contained in this press release regarding Phoenix Life Sciences
International, Limited and its subsidiaries, (the "Companies") may
constitute forward-looking statements or statements which may be
deemed or construed to be forward-looking statements. The words
"plan", "forecast", "anticipates", "estimate", "project", "intend",
"expect", "should", "believe," and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to, known and unknown risks,
uncertainties and other factors which could cause the Company's
actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. The risks, uncertainties and other
factors are more fully discussed in the Company's filings with the
U.S. Securities and Exchange Commission. All forward-looking
statements attributable to the Companies herein are expressly
qualified in their entirety by the above-mentioned cautionary
statement. The Companies disclaim any obligation to update
forward-looking statements contained in this press release, except
as may be required by law.
FOOD AND DRUG
ADMINISTRATION (FDA) DISCLOSURE
These statements
have not been evaluated by the FDA and therefore the products sold
by Phoenix Life Sciences International are not available in the
U.S.
LEGAL
DISCLOSURE
Phoenix Life
Sciences International does not sell or distribute any products in
the United States that are in violation of the United States
Controlled Substances Act (US.CSA). This company does not grow,
sell, and distribute cannabis-based products in the United States
and is solely involved with the legal distribution of medical
cannabis-based products within certain international markets
outside of the United States.
Investor
Contact:
Phone:
1.888.717.5655 or international +1.720.699.7222
E-mail:
investor.relations@phoenixlife.co
Media
Contact:
Kathryn
Reinhardt
CMW
Media
Kathryn@cmwmedia.com
619-972-3089
Phoenix Life Sciences (CE) (USOTC:PLSI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Phoenix Life Sciences (CE) (USOTC:PLSI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024